The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection
Open accessAbstract
Regulated by histone acetyltransferases and deacetylases (HDACs), histone acetylation is a key epigenetic mechanism controlling chromatin structure, DNA accessibility, and gene expression. HDAC inhibitors induce growth arrest, differentiation, and apoptosis of tumor cells and are used as anticancer agents. Here we describe the effects of HDAC inhibitors on microbial sensing by macrophages and dendritic cells in vitro and host defenses against infection in vivo. HDAC inhibitors down-regulated the expression of numerous host defense genes, including pattern recognition receptors, kinases, transcription regulators, cytokines, chemokines, growth factors, and costimulatory molecules as assessed by genome-wide microarray analyses or innate immune responses of macrophages and dendritic cells stimulated with Toll-like receptor agonists. HDAC inhibitors induced the expression of Mi-2β and enhanced the DNA-binding activity of the Mi-2/NuRD complex that acts as a transcriptional repressor of macrophage cytokine production. In vivo, HDAC inhibitors increased the susceptibility to bacterial and fungal infections but conferred protection against toxic and septic shock. Thus, these data identify an essential role for HDAC inhibitors in the regulation of the expression of innate immune genes and host defenses against microbial pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As drug inhibition of cellular deacetylases strongly attenuates pathogen-and immunogen-induced immune responses (139–141), it is tempting to speculate that acetylation plays a key role in modulating immune signaling pathways.”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Delaloye, J., Roger, T., Steiner, Q., Roy, D. L., Reymond, M. K., Akira, S., Pétrilli, V., Gómez, C. E., Perdiguero, B., Tschopp, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000480 · Cited by 307
Self-citationRetractedKorn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature reviews. Immunology · doi:10.1038/nri1001 · Cited by 4,007
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Haberland, M., Montgomery, R. L., & Olson, E. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,600
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,234
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature reviews. Immunology · doi:10.1038/nri1200 · Cited by 1,782
Self-citationHistone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
Extracellular histones are major mediators of death in sepsis
Xu, J., Zhang, X., Pelayo, R., Monestier, M., Ammollo, C. T., Semeraro, F., Taylor, F. B., Esmon, N. L., Lupu, F., & Esmon, C. T. (2009) · Nature Medicine · doi:10.1038/nm.2053 · Cited by 1,540
Cited by
Sorted by citations
Chang, P. V., Hao, L., Offermanns, S., & Medzhitov, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322269111 · Cited by 2,175
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Hotchkiss, R. S., Monneret, G., & Payen, D. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70001-x · Cited by 1,483
The role of short-chain fatty acids in immunity, inflammation and metabolism
Yao, Y., Cai, X. T., Fei, W., Ye, Y., Zhao, M., & Zheng, C. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1854675 · Cited by 793
Amino Assets: How Amino Acids Support Immunity
Kelly, B. L., & Pearce, E. L. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.010 · Cited by 666
Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells
Li, M., van Esch, B. C. A. M., Wagenaar, G. T. M., Garssen, J., Folkerts, G., & Henricks, P. A. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.003 · Cited by 650
Histone deacetylases as regulators of inflammation and immunity
Shakespear, M. R., Halili, M. A., Irvine, K. M., Fairlie, D. P., & Sweet, M. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.001 · Cited by 546
Gut Bacteria and Neurotransmitters
Dicks, L. M. T. (2022) · Microorganisms · doi:10.3390/microorganisms10091838 · Cited by 482
Regulation of short-chain fatty acids in the immune system
Liu, X., Shao, J.-H., Liao, Y.-T., Wang, L., Yuan, J., Dong, P.-J., Liu, Z., He, D., Li, C., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186892 · Cited by 464
Epigenetic regulation of macrophage polarization and function
Ivashkiv, L. B. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.11.001 · Cited by 407
Gonçalves, P., Araújo, J. R., & Santo, J. P. D. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx029 · Cited by 404
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 346
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation
Mullican, S. E., Gaddis, C. A., Alenghat, T., Nair, M. G., Giacomin, P. R., Everett, L. J., Feng, D., Steger, D. J., Schug, J., Artis, D., et al. (2011) · Genes & Development · doi:10.1101/gad.175950.111 · Cited by 314
HDAC inhibitor‐based therapies: Can we interpret the code?
New, M. I., Olzscha, H., & Thangue, N. B. L. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.003 · Cited by 315
Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators
Kaliman, P., Álvarez-López, M. J., Cosín-Tomás, M., Rosenkranz, M. A., Lutz, A., & Davidson, R. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.004 · Cited by 300
Wei, D. G., Chiang, V., Fyne, E., Balakrishnan, M., Barnes, T. L., Graupe, M., Hesselgesser, J., Irrinki, A., Murry, J. P., Stepan, G. J., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004071 · Cited by 272
Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?
Wyngene, L. V., Vandewalle, J., & Libert, C. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708712 · Cited by 269
Saleh, H. A., Yousef, M. H., & Abdelnaser, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.606069 · Cited by 269
Zinc binding groups for histone deacetylase inhibitors
Zhang, L., Zhang, J., Jiang, Q., Zhang, L., & Song, W. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1417274 · Cited by 240
Jain, N., Moeller, J., & Vogel, V. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121224 · Cited by 237
Myeloid-Derived Suppressor Cells in Sepsis
Schrijver, I. T., Théroude, C., & Roger, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00327 · Cited by 232
Self-citationRegulation of type 2 innate lymphoid cell–dependent airway hyperreactivity by butyrate
Thio, C. L., Chi, P., Lai, A. C., & Chang, Y. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.032 · Cited by 224
Grabiec, A. M., Korchynskyi, O., Tak, P. P., & Reedquist, K. A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.154211 · Cited by 211
Histone deacetylases as targets for treatment of multiple diseases
Tang, J., Yan, H., & Zhuang, S. (2013) · Clinical Science · doi:10.1042/cs20120504 · Cited by 204
(ECIL), O. B. O. T. E. C. O. I. I. L., Maschmeyer, G., Greef, J. D., Mellinghoff, S. C., Nosari, A., Thiébaut, A., Bergeron, A., Franquet, T., Blijlevens, N. M. A., & Maertens, J. A. (2019) · Leukemia · doi:10.1038/s41375-019-0388-x · Cited by 188
Emerging roles of lactate in acute and chronic inflammation
Fang, Y., Li, Z., Yang, L., Li, W., Wang, Y., Kong, Z., Miao, J., Chen, Y., Bian, Y., & Zeng, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01624-8 · Cited by 186
HDAC inhibitors and immunotherapy; a double edged sword?
Kroesen, M., Gielen, P. R., Brok, I. C., Armandari, I., Hoogerbrugge, P. M., & Adema, G. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2289 · Cited by 168
Sanford, J. A., Zhang, L.-J., Williams, M. R., Gangoiti, J. A., Huang, C.-M., & Gallo, R. L. (2016) · Science Immunology · doi:10.1126/sciimmunol.aah4609 · Cited by 166
HDAC inhibitors in parasitic diseases
Andrews, K. T., Haque, A., & Jones, M. K. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.97 · Cited by 165
Magnusson, M. K., Strid, H., Sapnara, M., Lasson, A., Bajor, A., Ung, K., & Öhman, L. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw051 · Cited by 164
Histone Deacetylase Inhibitors for Treating a Spectrum of Diseases Not Related to Cancer
Dinarello, C. A., Fossati, G., & Mascagni, P. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00116 · Cited by 160
Dichotomous engagement of HDAC3 activity governs inflammatory responses
Nguyen, H. C. B., Adlanmerini, M., Hauck, A. K., & Lazar, M. A. (2020) · Nature · doi:10.1038/s41586-020-2576-2 · Cited by 150
Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
Mazzone, R., Zwergel, C., Mai, A., & Valente, S. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0358-y · Cited by 151
Daskalaki, M., Tsatsanis, C., & Kampranis, S. C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26497 · Cited by 139
Giannoni, É., Guignard, L., Reymond, M. K., Perreau, M., Roth‐Kleiner, M., Calandra, T., & Roger, T. (2011) · Infection and Immunity · doi:10.1128/iai.00076-11 · Cited by 135
Self-citationRegulatory dendritic cells in autoimmunity: A comprehensive review
Liu, J., & Cao, X. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.011 · Cited by 136
White, C. A., Pone, E. J., Lam, T., Tat, C., Hayama, K. L., Li, G., Zan, H., & Casali, P. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401702 · Cited by 131
Zhang, L., Han, Y., Jiang, Q., Wang, C., Chen, X., Li, X., Xu, F., Jiang, Y., Wang, Q., & Xu, W. (2014) · Medicinal Research Reviews · doi:10.1002/med.21320 · Cited by 131
Leishmania donovani Infection Causes Distinct Epigenetic DNA Methylation Changes in Host Macrophages
Marr, A. K., MacIsaac, J. L., Jiang, R., Airo, A. M., Kobor, M. S., & McMaster, W. R. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004419 · Cited by 132
Lovatel, G. A., Elsner, V. R., Bertoldi, K., Vanzella, C., Moysés, F. D. S., Vizuete, A. F. K., Spindler, C. D. F., Cechinel, L. R., Netto, C. A., Muotri, A. R., et al. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.01.007 · Cited by 132
Sanford, J. A., O’Neill, A. M., Zouboulis, C. C., & Gallo, R. L. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800893 · Cited by 127
Jurdzinski, K. T., Potempa, J., & Grabiec, A. M. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00982-7 · Cited by 129
Epigenetic regulation of macrophage polarization in wound healing
Chen, C., Liu, T., Tang, Y., Luo, G., Liang, G., & He, W. (2023) · Burns & Trauma · doi:10.1093/burnst/tkac057 · Cited by 130
Cellular metabolism of myeloid cells in sepsis
Arts, R. J. W., Gresnigt, M. S., Joosten, L. A. B., & Netea, M. G. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0216-066r · Cited by 126
Epigenetic regulation in bacterial infections: targeting histone deacetylases
Grabiec, A. M., & Potempa, J. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1373063 · Cited by 119
The Emerging Role of Epigenetics in Inflammation and Immunometabolism
Raghuraman, S., Donkin, I., Versteyhe, S., Barrès, R., & Simar, D. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.06.008 · Cited by 120
de Groot, A. E., & Pienta, K. J. (2018) · Oncotarget · doi:10.18632/oncotarget.24556 · Cited by 124
Mukherjee, K., Fischer, R., & Vilcinskas, A. (2012) · Frontiers in Zoology · doi:10.1186/1742-9994-9-25 · Cited by 116
Gupta, K. D., Shakespear, M. R., Iyer, A., Fairlie, D. P., & Sweet, M. J. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2015.46 · Cited by 116
Ciarlo, E., Heinonen, T., Herderschee, J., Fenwick, C. W., Mombelli, M., Roy, D. L., & Roger, T. (2016) · Scientific Reports · doi:10.1038/srep37944 · Cited by 122
Self-citationMicrobial metabolites control gut inflammatory responses
Arpaia, N., & Rudensky, A. Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323183111 · Cited by 112
Immunomodulatory roles of microbiota-derived short-chain fatty acids in bacterial infections
Ranjbar, R., Vahdati, S. N., Tavakoli, S., Khodaie, R., & Behboudi, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111817 · Cited by 113
Kapellos, T. S., & Iqbal, A. J. (2016) · Mediators of Inflammation · doi:10.1155/2016/6591703 · Cited by 109
Acyldepsipeptide HDAC Inhibitor Production Induced in Burkholderia thailandensis
Biggins, J. B., Gleber, C. D., & Brady, S. F. (2011) · Organic Letters · doi:10.1021/ol200225v · Cited by 102
Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response
Zan, H., & Casali, P. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00631 · Cited by 118
Citrullinated histone H3: A novel target for the treatment of sepsis
Li, Y., Liu, Z., Liu, B., Zhao, T., Chong, W., Wang, Y., & Alam, H. B. (2014) · Surgery · doi:10.1016/j.surg.2014.04.009 · Cited by 100
Gu, L.-Z., Sun, H., & Chen, J. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.094 · Cited by 97
Shakespear, M. R., Hohenhaus, D. M., Kelly, G., Kamal, N. A., Gupta, P. K., Labzin, L. I., Schroder, K., Garceau, V., Barbero, S., Iyer, A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.496281 · Cited by 98
Gupta, K. D., Shakespear, M. R., Curson, J. E. B., Murthy, A. M. V., Iyer, A., Hodson, M. P., Ramnath, D., Tillu, V. A., von Pein, J. B., Reid, R. C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.007 · Cited by 101
How important are fatty acids in human health and can they be used in treating diseases?
Dicks, L. M. T. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2420765 · Cited by 99
den Bossche, J. V., Neele, A. E., Hoeksema, M. A., & de Winther, M. P. J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000109 · Cited by 102
Histone Deacetylase Inhibitors Impair Antibacterial Defenses of Macrophages
Mombelli, M., Lugrin, J., Rubino, I., Chanson, A.-L., Giddey, M., Calandra, T., & Roger, T. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir553 · Cited by 89
Self-citationCurrent trends in protein acetylation analysis
Diallo, I., Seve, M., Cunin, V., Minassian, F., Poisson, J., Michelland, S., & Bourgoin‐Voillard, S. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1559061 · Cited by 93
Histones: The critical players in innate immunity
Li, X., Ye, Y., Peng, K., Zeng, Z., Chen, L., & Zeng, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1030610 · Cited by 87
C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice
Kyme, P. A., Thoennissen, N. H., Tseng, C. W., Thoennissen, G. B., Wolf, A. J., Shimada, K., Krug, U. O., Lee, K., Müller‐Tidow, C., Berdel, W. E., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62070 · Cited by 90
Histone Deacetylases and Their Inhibition in Candida Species
Garnaud, C., Champleboux, M., Maubon, D., Cornet, M., & Govin, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01238 · Cited by 86
The role of epigenetic changes in preeclampsia
Kamrani, A., Alipourfard, I., Ahmadi‐Khiavi, H., Yousefi, M., Rostamzadeh, D., Izadi, M., & Ahmadi, M. (2019) · BioFactors · doi:10.1002/biof.1542 · Cited by 87
Cycon, K. A., Mulvaney, K. M., Rimsza, L. M., Persky, D. O., & Murphy, S. P. (2013) · Immunology · doi:10.1111/imm.12136 · Cited by 86
Kobayashi, T., Matsuoka, K., Sheikh, S. Z., Russo, S. M., Mishima, Y., Collins, C. B., de Zoeten, E. F., Karp, C. L., Ting, J. P. ‐., Sartor, R. B., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200042 · Cited by 83
Bandyopadhaya, A., Tsurumi, A., Maura, D., Jeffrey, K. L., & Rahme, L. G. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.174 · Cited by 82
Cross, D. L., Drury, R. E., Hill, J. W., & Pollard, A. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01363 · Cited by 83
Zhou, R., Gong, A., Chen, D., Miller, R. E., Eischeid, A. N., & Chen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065153 · Cited by 77
Epigenetics in sepsis: targeting histone deacetylases.
Ciarlo, E., Savva, A., & Roger, T. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.004 · Cited by 72
Self-citationRegulation of Immune Responses by Histone Deacetylase Inhibitors
Licciardi, P. V., & Karagiannis, T. C. (2012) · ISRN Hematology · doi:10.5402/2012/690901 · Cited by 75
Corrêa, R. O., Vieira, A. T., Sernaglia, E. M., Lancellotti, M., Vieira, A. T., Ávila-Campos, M. J., Rodrigues, H. G., & Vinolo, M. A. R. (2017) · Cellular Microbiology · doi:10.1111/cmi.12720 · Cited by 76
Mechanism of Action for HDAC Inhibitors—Insights from Omics Approaches
Li, W., & Sun, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071616 · Cited by 77
Wu, J., Dong, L., Zhang, M., Jia, M., Zhang, G., Qiu, L., Ji, M., & Yang, J. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1159-0 · Cited by 74
Roger, T., Delaloye, J., Chanson, A.-L., Giddey, M., Roy, D. L., & Calandra, T. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis673 · Cited by 75
Self-citationNair, V. S., Saleh, R., Toor, S. M., Taha, R. Z., Ahmed, A., Kurer, M. A., Murshed, K., Alajez, N. M., Nada, M. A., & Elkord, E. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-0808-9 · Cited by 72
Cole, J., Aberdein, J., Jubrail, J., & Dockrell, D. H. (2014) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2014.08.004 · Cited by 71
Zhang, H., Du, ., Yang, Q., & Zhu, M. J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.09.020 · Cited by 72
Liu, M., Zhou, J., Chen, Z., & Cheng, A. S. L. (2016) · The Journal of Pathology · doi:10.1002/path.4832 · Cited by 69
Modulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
Woan, K. V., Sahakian, E., Sotomayor, E. M., Seto, E., & Villagra, A. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.96 · Cited by 71
Epigenomic regulation of host–microbiota interactions
Alenghat, T., & Artis, D. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.09.007 · Cited by 72
Kelly‐Sell, M. J., Kim, Y. H., Straus, S., Benoit, B. M., Harrison, C., Sutherland, K., Armstrong, R. J., Weng, W., Showe, L. C., Wysocka, M., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23112 · Cited by 70
Inhibiting epigenetic enzymes to improve atherogenic macrophage functions
den Bossche, J. V., Neele, A. E., Hoeksema, M. A., de Heij, F., Boshuizen, M. C. S., van der Velden, S., de Boer, V. C. J., Reedquist, K. A., & de Winther, M. P. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.029 · Cited by 70
Chaix, R., Fagny, M., Cosín‐Tomás, M., Alvarez-López, M., Lemée, L., Regnault, B., Davidson, R. J., Antoine Lutz, A., & Kaliman, P. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.11.003 · Cited by 82
EZH2 in Bladder Cancer, a Promising Therapeutic Target
Martínez‐Fernández, M., Rubio, C., Segovia, C., López-Calderón, F., Dueñas, M., & Paramio, J. M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126000 · Cited by 68
Lugrin, J., Ciarlo, E., Santos, A., Grandmaison, G., Dos Santos, I., Le Roy, D., & Roger, T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.004 · Cited by 67
Self-citationThe Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology
Greco, T. M., Diner, B. A., & Cristea, I. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085527 · Cited by 67
Soria-Castro, R., Schcolnik‐Cabrera, A., Rodríguez-López, G. M., Campillo-Navarro, M., Puebla‐Osorio, N., Estrada-Parra, S. A., Estrada‐García, I., Chacón‐Salinas, R., & Chávez-Blanco, A. D. (2019) · Journal of Immunology Research · doi:10.1155/2019/9678098 · Cited by 72
Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection
Seshadri, C., Sedaghat, N., Campo, M., Peterson, G. J., Wells, R. D., Olson, G. S., Sherman, D. R., Stein, C. M., Mayanja‐Kizza, H., Shojaie, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175844 · Cited by 66
Histone Deacetylase Inhibitors as Immunomodulators in Cancer Therapeutics
Shen, L., Orillion, A. R., & Пили, Р. (2016) · Epigenomics · doi:10.2217/epi.15.118 · Cited by 66
Metabolism and acetylation in innate immune cell function and fate
Cameron, A. M., Lawless, S. J., & Pearce, E. J. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.10.003 · Cited by 65
Toussirot, É., Abbas, W., Khan, K. A., Tissot, M., Jeudy, A., Baud, L., Bertolini, E., Wendling, D., & Herbein, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070939 · Cited by 63
Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model
Li, Y., Zhao, T., Liu, B., Halaweish, I. F., Mazitschek, R., Duan, X., & Alam, H. B. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000510 · Cited by 63
Ariffin, J. K., Gupta, K. D., Kapétanovic, R., Iyer, A., Reid, R. C., Fairlie, D. P., & Sweet, M. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01876-15 · Cited by 63
Moores, R., Brilha, S., Schutgens, F., Elkington, P. T., & Friedland, J. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00602 · Cited by 65
Promising targets based on pattern recognition receptors for cancer immunotherapy
Bai, L., Li, W., Zheng, W., Xu, D., Chen, N., & Cui, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105017 · Cited by 67
Involvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats
Tan, L., Zhang, Y., Han, D., Hua, R., Guo, B., Hu, S.-Q., Yan, X., & Xu, T. J. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8468-4 · Cited by 61
Metadata
- Authors
- Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A.-L., Reymond, M. K., Miconnet, I., Schrenzel, J., François, P., & Calandra, T.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland;
- University Hospital of Geneva (CH)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-01-27
- Volume
- 117
- Issue
- 4
- Pages
- 1205-1217
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2066887945
- Cited by
- 341
- References
- 51
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 13 · 2023: 17 · 2022: 23 · 2021: 23 · 2020: 26 · 2019: 18 · 2018: 24 · 2017: 23 · 2016: 38 · 2015: 23 · 2014: 28 · 2013: 28 · 2012: 24
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- histone deacetylase inhibitors, innate immunity, TLR agonists, macrophages, dendritic cells, histone acetylation, epigenetic regulation, NuRD complex, host defense genes, cytokine production, bacterial infection susceptibility, fungal infection susceptibility, septic shock, pattern recognition receptors
- MeSH terms
- Animals, Cells, Cultured, Disease Models, Animal, Drug Evaluation, Preclinical, Female, Gene Expression Regulation, Humans, Immunity, Innate, Infections, Macrophages, Mice, Inbred BALB C, Down-Regulation, Gene Expression Profiling, Microarray Analysis, Toll-Like Receptors, Mice, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review